Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B

World Journal of Gastroenterology

Volumn 11, Issue 19, 2005, Pages 2892-2899

  Liu, Ping ^a   Hu, Yi Yang ^a   Liu, Cheng ^a   Xu, Lie Ming ^a   Liu, Cheng Hai ^a   Sun, Ke Wei ^b   Hu, De Chang ^c   Yin, You Kuan ^c   Zhou, Xia Qiu ^d   Wan, Mo Bin ^e   Cai, Xiong ^f   Zhang, Zhi Qing ^g   Ye, Jun ^h   Zhou, Ren Xing ⁱ   He, Jia ^j   Tang, Bao Zhang ^k  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Hunan College of TCM   (China)

^c FUDAN UNIVERSITY   (China)

^d SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

^f SECOND MILITARY MEDICAL UNIVERSITY   (China)

^g 4th People Hospital of Huaian City   (China)

^h Shanghai Putuo District Central Hospital   (China)

ⁱ Shanghai Modern Technique Co Ltd for TCM   (China)

^j SECOND MILITARY MEDICAL UNIVERSITY   (China)

^k Yunnan College of Art   (China)

more..

Author keywords

Chronic hepatitis B; Fuzhenghuayu capsule

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHINESE DRUG; FUZHENGHUAYU; HELUOSHUGAN; PLANT MEDICINAL PRODUCT; SERUM ALBUMIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; B SCAN; BLOOD EXAMINATION; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFLAMMATION; KIDNEY FUNCTION TEST; LIVER BIOPSY; LIVER EXAMINATION; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER HISTOLOGY; MULTICENTER STUDY; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEROLOGY; SPLEEN EXAMINATION; STAGING; STATISTICAL ANALYSIS; URINALYSIS;

EID: 20344397684     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i19.2892     Document Type: Article

References (13)

1. Liu P, Liu C, Chen GC, Hu YY, Xu LM, Lu P, Yang JL, Yan RM, Ji Q, Chu F. Effect of fuzheng huayu 319 capsule on serological parameters of fibrosis in treating chronic hepatitis B. Zhongguo Zhongxiyi Jiehe Zazhi 1996; 16: 588-592
2. Liu P, Liu C, Hu YY. Effect of fuzheng huayu recipe in treating posthepatititic cirrhosis. Zhongguo Zhongxiyi Jiehe Zazhi 1996; 16: 459-462
3. Zu WR, Wang TL, Zhou TH, Zhang TH. Diagnosis, grading and staging for chronic hepatitis. Chin J Dis 1996; 16: 277-281
4. Anonymous. Protocol for preventing and treating viral hepatitis (experimental implementation). Chin J Inter Med 1995; 34: 788-791
5. Wang TL, Liu X, Zhou YP, He JW, Zhang J, Li NZ, Duan ZP, Wang BE. A semiquntitative scoring system for assessment of hepatic inflammation and fibrosis in chronic viral hepatitis. Chin J Hepatol 1998; 6: 195-197
6. Liu P, Liu CH, Liu C, Xu LM. Serum Pharmacological effcts of fuzheng huayu decoction on ito cell proliferation and collagen synthesis in rats. CJIM 1998; 4: 118-122
7. She WN, Hu DC, Zhou CH. Clinical study of ganping capsule in treating liver fibrosis in chronic hepatitis B. Chin Hepatol 2002; 7: 254-255
8. Liu P, Liu C. Experimental study of the effect of fuzheng huayu 319 recipe on inhibiting liver fibrosis. Progress in pharmacological and clinical study of of traditional Chinese medicine (Vol 4 edited by Zhou Jinhuang Wang Jianhua). Press Millitary Med 1996: 314-321
9. Liu CH, Wang XL, Liu P. Serapharmacological effect of fuzheng huayu 319 decoction on expression of type I collagen and transforming growth factor β1 in hepatic stellate cells. Zhongguo Zhongxiyi Jiehe Zazhi 1999; 19: 412-414
10. Liu P, Wu DZ, Liu CH. Mechanism study on combination of Chinese herbs formula to support anti-pathogenic ability and dissipate blood stasis in promoting reversion of liver fibrosis. Act Shanghai Univ TCM 2002; 16: 37-41
11. Murawaki Y, Ikuta Y, Koda M, Yamada S, Kawasaki H. Comparison of serum 7S fragment of type IV collagen and serum cetral triple-helix of type IV collagen for assessment of liver fibrosis in patients with chronic viral liver disease. J Hepatol 1996; 24: 148-154
12. Murawaki Y, Ikuta Y, Koda M, Nishimura Y, Kawasaki H. Clinical significance of serum hyaluronan in patients with chronic viral liver disease. J Gastroenterol Hepatol 1996; 11: 459-465
13. Wang BE. Diagnosis and evaluation of seriousness of liver fibrosis. Chin J Heptol 1998; 6: 193-194